Table 5.

Adverse events

	Fluorescence group, n=365	White light group, n=361
Patients experiencing AEs, n (%)	202 (48.0%)	193 (50.7%)
Total AEs, n	562	476
Mild to moderate, n	525	455
Most common AEs
Renal and urinary disorders	31.4%	32.0%
	all patients/treatment-related
- Haematuria	63 (15%)/11 (2.6%)	64 (16.8%)
- Dysuria	40 (9.5%)/5 (1.2%)	28 (7.3%)
- Bladder spasm	20 (4.8%)/4 (1.0%)	18 (4.7%)
- Urinary retention	19 (4.5%)/4 (1.0%)	14 (3.7%)
- Bladder pain	17 (4.0%)/4 (1.0%)	13 (3.4%)
Serious AEs,	51	39
Patients, n (%)	39 (9.3%)	32 (8.4%)